RETRACTED: Potential of bone marrow mesenchymal stem cells in management of Alzheimer's disease in female rats
- 7 July 2014
- journal article
- retracted article
- Published by Wiley in Cell Biology International
- Vol. 38 (12) , 1367-1383
Abstract
Alzheimer's disease (AD) has been called the disease of the century with significant clinical and socioeconomic impacts. Pharmacological treatment has limited efficacy and only provides symptomatic relief without long-term cure. Accordingly, there is an urgent need to develop novel and effective medications for AD. Stem cell-based therapy is a promising approach to handling neurodegenerative diseases. Therefore, the current study aimed to explore the possible therapeutic role of single intravenous injection of bone marrow derived mesenchymal stem cells (BM-MSCs) after 4 months in management of AD in the experimental model. The work also extended to compare the therapeutic potential of BM-MSCs with 2 conventional therapies of AD; rivastigmine and cerebrolysin administered daily. BM-MSCs were able to home at the injured brains and produced significant increases in the number of positive cells for choline acetyltransferase (ChAT) and survivin expression, as well as selective AD indicator-1 (seladin-1) and nestin gene expression. Histopathological examination indicated that BM-MSCs could remove beta-amyloid plaques from hippocampus. Significant improvement in these biomarkers was similar to or better sometimes than the reference drugs, clearly showing the potential therapeutic role of BM-MSCs against AD through their anti-apoptotic, neurogenic and immunomodulatory properties.Keywords
This publication has 79 references indexed in Scilit:
- Neurogenic and cardiomyogenic differentiation of mesenchymal stem cells isolated from minipig bone marrowResearch in Veterinary Science, 2012
- Mesenchymal stem cells inhibition of chronic ethanol-induced oxidative damage via upregulation of phosphatidylinositol-3-kinase/Akt and modulation of extracellular signal-regulated kinase 1/2 activation in PC12 cells and neuronsNeuroscience, 2010
- Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of CerebrolysinActa Neuropathologica, 2009
- Bone marrow-derived mesenchymal stem cells reduce brain amyloid-β deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse modelNeuroscience Letters, 2009
- Role of Dickkopf-1, an Antagonist of the Wnt/β-Catenin Signaling Pathway, in Estrogen-Induced Neuroprotection and Attenuation of Tau PhosphorylationJournal of Neuroscience, 2008
- Neuronal differentiation of human mesenchymal stem cells: Changes in the expression of the Alzheimer's disease-related gene seladin-1Experimental Cell Research, 2006
- Alzheimer's diseaseThe Lancet, 2006
- Mesenchymal Stem Cells in the Wharton's Jelly of the Human Umbilical CordStem Cells, 2004
- Turning Blood into Brain: Cells Bearing Neuronal Antigens Generated in Vivo from Bone MarrowScience, 2000
- NGF-Mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: Evidence for a physiological role of NGF in the brain?Developmental Brain Research, 1983